Opinion|Videos|April 26, 2024

RCC: Treatment Goals in the Third-Line Setting

Focusing on VEGF TKIs available for the treatment of patients with metastatic renal cell carcinoma, the panel discusses the goals of therapy in the third-line setting.


Latest CME